- €1.00bn
- €569.49m
- €1.60bn
- 82
- 47
- 97
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.06 | ||
| PEG Ratio (f) | 2.94 | ||
| EPS Growth (f) | 7.71% | ||
| Dividend Yield (f) | 1.06% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.77 | ||
| Price to Tang. Book | 0.89 | ||
| Price to Free Cashflow | 17.55 | ||
| Price to Sales | 0.63 | ||
| EV to EBITDA | 5.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.34% | ||
| Return on Equity | 3.4% | ||
| Operating Margin | 3.04% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1,360.16 | 1,402.01 | 1,446.09 | 1,463.98 | 1,595.62 | 1,683 | 1,751 | 4.12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -81.72 | +263.94 | -21.86 | +72.42 | +11.58 | +6.5 | +10.14 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Rhoen Klinikum AG is a Germany-based provider of health care services. The Company operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
Directors
- Jan Hacker CSU
- Jan Liersch CSU
- Christian Hoftberger CEO
- Georg Schulze VSU
- Stefan Stranz CFO
- Gunther Weiss COO (54)
- Bernd Griewing MGB
- Peter Berghoefer SUB
- Nicole Damani SUB
- Julia Dannath Schuh SUB
- Regina Dickey SUB
- Peter Ducke SUB
- Leopold Eberhart SUB
- Irmtraut Gurkan SUB
- Kai Hankeln SUB
- Martin Mandewirth SUB
- Thomas Pillukat SUB
- Christine Reissner SUB
- Hafid Rifi SUB
- Oliver Salomon SUB
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 5th, 1988
- Public Since
- November 27th, 1989
- No. of Employees
- 18,744
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
XETRA- Shares in Issue
- 66,938,470
- Address
- Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616
- Web
- https://www.rhoen-klinikum-ag.com/
- Phone
- +49 9771650
- Contact
- Julian Schmitt
- Auditors
- KPMG AG Wirtschaftsprufungsgesellschaft
Upcoming Events for RHK
Rhoen Klinikum AG Annual Shareholders Meeting
Dividend For RHKG.DE - 0.1000 EUR
Half Year 2025 Rhoen Klinikum AG Earnings Release
Similar to RHK
Doccheck AG
XETRA
FamiCord AG
XETRA
FAQ
What is the Rhoen Klinikum AG share price?
As of Today at 22:56 UTC, shares in Rhoen Klinikum AG are trading at €15.00. This share price information is delayed by 15 minutes.
How has the Rhoen Klinikum AG share price performed this year?
Shares in Rhoen Klinikum AG last closed at €15.00 and the price had moved by +17.19% over the past 365 days. In terms of relative price strength the Rhoen Klinikum AG share price has outperformed the FTSE Global All Cap Index by +14.25% over the past year.
What are the analyst and broker recommendations for Rhoen Klinikum AG?
The overall consensus recommendation for Rhoen Klinikum AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Rhoen Klinikum AG dividend yield?
The Rhoen Klinikum AG dividend yield is 0.67% based on the trailing twelve month period.
Does Rhoen Klinikum AG pay a dividend?
Last year, Rhoen Klinikum AG paid a total dividend of €0.10, and it currently has a trailing dividend yield of 0.67%.Looking ahead, shares in Rhoen Klinikum AG are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-06-06.
When does Rhoen Klinikum AG next pay dividends?
Rhoen Klinikum AG are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-06-06. The historic dividend yield on Rhoen Klinikum AG shares is currently 0.67%.
How do I buy Rhoen Klinikum AG shares?
To buy shares in Rhoen Klinikum AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Rhoen Klinikum AG?
As of the previous close price of €15.00, shares in Rhoen Klinikum AG had a market capitalisation of €1.00bn.
Where are Rhoen Klinikum AG shares listed?
Here are the trading details for Rhoen Klinikum AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: RHK
What kind of share is Rhoen Klinikum AG?
Based on an overall assessment of its quality, value and momentum Rhoen Klinikum AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Rhoen Klinikum AG share price forecast for 2025?
The analyst consensus target price for shares in Rhoen Klinikum AG is €14.00. That is 6.67% below the last closing price of €15.00.
Analysts covering Rhoen Klinikum AG currently have a consensus Earnings Per Share (EPS) forecast of €0.69 for the next financial year.
Find out moreWhat is the trend in the Rhoen Klinikum AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rhoen Klinikum AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +17.04%.
As of the last closing price of €15.00, shares in Rhoen Klinikum AG were trading +14.09% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Rhoen Klinikum AG PE Ratio?
The Rhoen Klinikum AG PE ratio based on its reported earnings over the past 12 months is 21.06. The shares last closed at €15.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Rhoen Klinikum AG?
Rhoen Klinikum AG's management team is headed by:
- Jan Hacker - CSU
- Jan Liersch - CSU
- Christian Hoftberger - CEO
- Georg Schulze - VSU
- Stefan Stranz - CFO
- Gunther Weiss - COO
- Bernd Griewing - MGB
- Peter Berghoefer - SUB
- Nicole Damani - SUB
- Julia Dannath Schuh - SUB
- Regina Dickey - SUB
- Peter Ducke - SUB
- Leopold Eberhart - SUB
- Irmtraut Gurkan - SUB
- Kai Hankeln - SUB
- Martin Mandewirth - SUB
- Thomas Pillukat - SUB
- Christine Reissner - SUB
- Hafid Rifi - SUB
- Oliver Salomon - SUB